BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 30115896)

  • 1. Interaction between Tumor-Associated Dendritic Cells and Colon Cancer Cells Contributes to Tumor Progression via CXCL1.
    Hsu YL; Chen YJ; Chang WA; Jian SF; Fan HL; Wang JY; Kuo PL
    Int J Mol Sci; 2018 Aug; 19(8):. PubMed ID: 30115896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemokine (C-C Motif) Ligand 5 is Involved in Tumor-Associated Dendritic Cell-Mediated Colon Cancer Progression Through Non-Coding RNA MALAT-1.
    Kan JY; Wu DC; Yu FJ; Wu CY; Ho YW; Chiu YJ; Jian SF; Hung JY; Wang JY; Kuo PL
    J Cell Physiol; 2015 Aug; 230(8):1883-94. PubMed ID: 25546229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nesfatin-1/Nucleobindin-2 enhances cell migration, invasion, and epithelial-mesenchymal transition via LKB1/AMPK/TORC1/ZEB1 pathways in colon cancer.
    Kan JY; Yen MC; Wang JY; Wu DC; Chiu YJ; Ho YW; Kuo PL
    Oncotarget; 2016 May; 7(21):31336-49. PubMed ID: 27150059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. microRNA-374a suppresses colon cancer progression by directly reducing CCND1 to inactivate the PI3K/AKT pathway.
    Chen Y; Jiang J; Zhao M; Luo X; Liang Z; Zhen Y; Fu Q; Deng X; Lin X; Li L; Luo R; Liu Z; Fang W
    Oncotarget; 2016 Jul; 7(27):41306-41319. PubMed ID: 27191497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HMGA2 induces transcription factor Slug expression to promote epithelial-to-mesenchymal transition and contributes to colon cancer progression.
    Li Y; Zhao Z; Xu C; Zhou Z; Zhu Z; You T
    Cancer Lett; 2014 Dec; 355(1):130-40. PubMed ID: 25218351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of platelet protease-activated receptor-1 induces epithelial-mesenchymal transition and chemotaxis of colon cancer cell line SW620.
    Jia Y; Zhang S; Miao L; Wang J; Jin Z; Gu B; Duan Z; Zhao Z; Ma S; Zhang W; Li Z
    Oncol Rep; 2015 Jun; 33(6):2681-8. PubMed ID: 25846512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CXCL2/CXCR2 axis induces cancer stem cell characteristics in CPT-11-resistant LoVo colon cancer cells via Gαi-2 and Gαq/11.
    Chen MC; Baskaran R; Lee NH; Hsu HH; Ho TJ; Tu CC; Lin YM; Viswanadha VP; Kuo WW; Huang CY
    J Cell Physiol; 2019 Jul; 234(7):11822-11834. PubMed ID: 30552676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospero homeobox 1 promotes epithelial-mesenchymal transition in colon cancer cells by inhibiting E-cadherin via miR-9.
    Lu MH; Huang CC; Pan MR; Chen HH; Hung WC
    Clin Cancer Res; 2012 Dec; 18(23):6416-25. PubMed ID: 23045246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CXCL1 from tumor-associated lymphatic endothelial cells drives gastric cancer cell into lymphatic system via activating integrin β1/FAK/AKT signaling.
    Wang Z; Wang Z; Li G; Wu H; Sun K; Chen J; Feng Y; Chen C; Cai S; Xu J; He Y
    Cancer Lett; 2017 Jan; 385():28-38. PubMed ID: 27832972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lung tumor-associated dendritic cell-derived amphiregulin increased cancer progression.
    Hsu YL; Huang MS; Cheng DE; Hung JY; Yang CJ; Chou SH; Kuo PL
    J Immunol; 2011 Aug; 187(4):1733-44. PubMed ID: 21742971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-17 induces epithelial-mesenchymal transition consistent with the cancer stem cell phenotype by regulating CYP7B1 expression in colon cancer.
    Xi XP; Zhuang J; Teng MJ; Xia LJ; Yang MY; Liu QG; Chen JB
    Int J Mol Med; 2016 Aug; 38(2):499-506. PubMed ID: 27278684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phenotypic subpopulations of metastatic colon cancer stem cells: genomic analysis.
    Botchkina IL; Rowehl RA; Rivadeneira DE; Karpeh MS; Crawford H; Dufour A; Ju J; Wang Y; Leyfman Y; Botchkina GI
    Cancer Genomics Proteomics; 2009; 6(1):19-29. PubMed ID: 19451087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcriptional repression of miR-200 family members by Nanog in colon cancer cells induces epithelial-mesenchymal transition (EMT).
    Pan Q; Meng L; Ye J; Wei X; Shang Y; Tian Y; He Y; Peng Z; Chen L; Chen W; Bian X; Wang R
    Cancer Lett; 2017 Apr; 392():26-38. PubMed ID: 28163188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The tumour suppressor effects and regulation of cancer stem cells by macrophage migration inhibitory factor targeted miR-451 in colon cancer.
    Mamoori A; Wahab R; Vider J; Gopalan V; Lam AK
    Gene; 2019 May; 697():165-174. PubMed ID: 30802541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin-8, but not the Related Chemokine CXCL1, Sustains an Autocrine Circuit Necessary for the Properties and Functions of Thyroid Cancer Stem Cells.
    Liotti F; Collina F; Pone E; La Sala L; Franco R; Prevete N; Melillo RM
    Stem Cells; 2017 Jan; 35(1):135-146. PubMed ID: 27577959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. M2-like macrophages induce colon cancer cell invasion via matrix metalloproteinases.
    Vinnakota K; Zhang Y; Selvanesan BC; Topi G; Salim T; Sand-Dejmek J; Jönsson G; Sjölander A
    J Cell Physiol; 2017 Dec; 232(12):3468-3480. PubMed ID: 28098359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bmi-1 promotes the invasion and migration of colon cancer stem cells through the downregulation of E-cadherin.
    Zhang Z; Bu X; Chen H; Wang Q; Sha W
    Int J Mol Med; 2016 Oct; 38(4):1199-207. PubMed ID: 27600678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BMP-2 induces motility and invasiveness by promoting colon cancer stemness through STAT3 activation.
    Kim BR; Oh SC; Lee DH; Kim JL; Lee SY; Kang MH; Lee SI; Kang S; Joung SY; Min BW
    Tumour Biol; 2015 Dec; 36(12):9475-86. PubMed ID: 26124007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mesenchymal Stem Cells Induce Epithelial to Mesenchymal Transition in Colon Cancer Cells through Direct Cell-to-Cell Contact.
    Takigawa H; Kitadai Y; Shinagawa K; Yuge R; Higashi Y; Tanaka S; Yasui W; Chayama K
    Neoplasia; 2017 May; 19(5):429-438. PubMed ID: 28433772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CXCL1-LCN2 paracrine axis promotes progression of prostate cancer via the Src activation and epithelial-mesenchymal transition.
    Lu Y; Dong B; Xu F; Xu Y; Pan J; Song J; Zhang J; Huang Y; Xue W
    Cell Commun Signal; 2019 Sep; 17(1):118. PubMed ID: 31500632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.